R. Lange et al., DYNAMIC CARDIOMYOPLASTY - INDICATION, SURGICAL TECHNIQUE, AND RESULTS, The thoracic and cardiovascular surgeon, 43(5), 1995, pp. 243-251
The efficacy of dynamic cardiomyoplasty is still controversial. To dat
e more than 400 patients have been operated worldwide. In recent years
the indication and the surgical technique have become more uniform, w
hich makes results from different centers eligible for comparison. We
performed cardiomyoplasty exclusively in patients with contraindicatio
ns for heart transplantation, such as chronic and recurrent infections
or severe, irreversible sequelae of diabetes. Between August 1990 and
October 1994, 8 isolated cardiomyoplasty procedures were performed in
patients with cardiomyopathy (EF 14-32%, all in NYHA III). One patien
t died 2 months after surgery. Reported are the results of 7 patients
after a mean follow-up of 41.1 +/- 14.1 months. Considerable symptomat
ic improvement was found in 6 of 7 patients, 3 of whom went back to wo
rk. One patient with severe pulmonary hypertension exhibited no improv
ement. In the others NYHA class improved by at least one. Echocardiogr
aphy showed an increase in fractional shortening in all patients. LVEF
increased from 21.2 +/- 5.2 % to 38.1 +/- 15.9 % (n = 7, p<0.015) at
1 year, to 36.6 +/- 17.6% (n = 6, p < 0.05) at two years, and to 36.4
+/- 18.9 % (n = 5, NS) at three years. Pulmonary artery pressure tende
d to decrease at rest over time. Resting lung function showed no chang
e of vital capacity and FEV(1). No significant change in exercise leve
l and maximal O-2-consumption during treadmill testing was observed. O
ne patient died 34 months after the operation from sudden death. Our p
reliminary results show that patients after cardiomyoplasty may exhibi
t an impressive clinical improvement with less striking changes of obj
ective hemodynamic parameters. This data is in agreement with the resu
lts of all other investigators. Some possible mechanisms of action are
discussed and a risk profile suggested. According to the current stat
e of experience with cardiomyoplasty, we do not consider this method a
n alternative to heart transplantation, but reserve it for patients wi
th contraindications for heart transplantation.